Personalized Nutrition and Continuous Glucose Monitoring for Type 2 Diabetes
Unblinded CGM/Nutrition Therapy
+ Blinded CGM/Nutrition Therapy
+ Unblinded CGM/No Nutrition Therapy
Diabetes Mellitus+3
+ Diabetes Mellitus, Type 2
+ Endocrine System Diseases
Treatment Study
Summary
Study start date: July 14, 2025
Actual date on which the first participant was enrolled.This study is focused on improving the health of people with type 2 diabetes by looking at how personalized nutrition plans can help manage their condition. The study uses a technology called continuous glucose monitoring (CGM) to tailor nutrition advice specifically for each participant. Type 2 diabetes often requires careful management of diet to keep blood sugar levels in check, and this study aims to see if using CGM can make nutrition therapy more effective compared to standard methods. Participants in the study will receive a personalized nutrition plan based on feedback from a continuous glucose monitor, which is a device that tracks blood sugar levels throughout the day. The study will compare this personalized approach to other standard nutrition interventions to evaluate which is more beneficial in controlling diabetes. Participants will likely have to follow specific dietary guidelines and may need to wear the CGM device regularly to collect data. The main goal is to assess how these personalized plans affect diabetes management, potentially leading to better health outcomes for people with type 2 diabetes.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.72 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.4 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
ExperimentalGroup IV
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location